Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS)

Historical Holders from Q2 2022 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
RGLS
Shares outstanding
66,505,186
All holders as of 30 Sep 2025
Q3 2025
Number of holders
0
Price from insider filings
$8.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 3.9% $9,086,956 2,696,426 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
Point72 Asset Management, L.P. 0.3% -93% $1,977,487 -$30,197,722 241,157 -94% Point72 Asset Management, L.P. 30 Jun 2025

Institutional Holders of Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share - Put (RGLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 0
2025 Q2 0 $0 -$105,304,835 816% 0
2025 Q1 53,596,381 $105,311,940 +$3,105,761 175% 74
2024 Q4 53,508,570 $84,543,374 -$5,126,517 158% 68
2024 Q3 56,729,933 $89,079,771 +$3,280,059 157% 69
2024 Q2 54,841,321 $97,892,529 +$13,518,084 178.5% 60
2024 Q1 45,620,114 $128,657,473 +$103,077,800 288% 42
2023 Q4 9,168,367 $11,735,268 +$40,056 128% 23
2023 Q3 8,956,428 $12,343,312 +$1,002,811 137.14% 22
2023 Q2 8,228,751 $12,096,772 +$2,407,893 147% 21
2023 Q1 6,598,665 $5,593,075 -$77,466 84.75% 22
2022 Q4 6,670,905 $9,138,408 -$4,945 137% 21
2022 Q3 6,668,921 $11,336,000 +$3,422,009 169.92% 19
2022 Q2 4,622,322 $9,565,000 +$9,565,000 206.14% 22